Iron Depletion: Medications, Symptoms & Food Sources

Iron is the oxygen-carrying mineral at the center of hemoglobin in every red blood cell and myoglobin in every muscle fiber. Without adequate iron, your tissues are literally oxygen-starved — which is why iron deficiency produces that distinctive exhaustion that no amount of sleep resolves. Beyond oxygen transport, iron is an essential cofactor for mitochondrial energy production (cytochrome c oxidase in the electron transport chain), DNA synthesis, and neurotransmitter production via tyrosine hydroxylase (dopamine) and tryptophan hydroxylase (serotonin). Iron deficiency is the most common nutritional deficiency worldwide, affecting approximately 25% of the global population. The CTD database catalogs 948 randomized controlled trials involving iron across 2,633,550 patients, with therapeutic evidence spanning iron-deficiency anemia, cognitive development, restless leg syndrome, and immune function.

What makes iron depletion particularly insidious is how the standard lab 'normal' ranges mask true deficiency. Most labs flag ferritin below 20 ng/mL as low — but symptoms of iron deficiency (fatigue, hair loss, brain fog, cold intolerance) reliably begin below 40 ng/mL, and optimal function requires ferritin above 70 ng/mL. This means millions of people are told their iron is 'normal' while operating at a fraction of their potential energy capacity. Medication-driven iron depletion compounds this problem: PPIs block the stomach acid needed to absorb iron, NSAIDs cause microscopic GI bleeding that drains iron stores, and fluoroquinolone antibiotics chelate iron in the gut. PubMed indexes 42,778 articles on iron, with 318 meta-analyses confirming that iron repletion improves fatigue, cognitive function, exercise capacity, and quality of life when ferritin is brought from the sub-optimal range into the 70-150 ng/mL target zone.

The PPI-plus-NSAID combination is the most dangerous iron double depletion pattern, and it is prescribed to millions of patients simultaneously. PPIs block the stomach acid required to absorb dietary iron, cutting the supply side. NSAIDs cause microscopic GI bleeding that continuously drains iron stores, accelerating the demand side. This creates a supply-and-demand squeeze where you are absorbing less iron while losing more iron with every dose. The irony is that PPIs are frequently prescribed specifically to protect the stomach from NSAID-induced damage — solving the bleeding risk while creating an absorption deficit. Patients on both drug classes should have ferritin monitored every six months and supplement proactively with iron bisglycinate and vitamin C.

The ADHD-stimulant-plus-poor-diet pattern is an underrecognized iron depletion risk, particularly in children and young adults. Stimulant medications (methylphenidate, amphetamine) suppress appetite, reducing iron intake from food. Simultaneously, stimulants increase dopamine turnover, which increases the demand for iron as a cofactor for tyrosine hydroxylase — the enzyme that synthesizes dopamine. This creates a functional iron deficit where demand rises as supply falls. Iron status directly affects ADHD symptom severity and stimulant medication response, so iron-depleted patients may receive dose escalations when iron repletion would have been the more effective intervention. Ferritin testing should be standard practice before and during stimulant therapy.